We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
In 2017, Eurofins Scientific acquired Alphora Research Inc. to support Eurofins’ drug development platform. Starting in July, the commercial brand for Eurofins Alphora will be ...